Atea Pharmaceuticals, Inc. (AVIR) Operating income 2018–2025
Atea Pharmaceuticals, Inc. (AVIR) annual operating income history from SEC filings — each fiscal year as reported.
-$180.9MFY2025 · since FY2018: -$9.5M → -$180.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$180.9M | +6.3% |
| FY2024 | -$192.9M | -17.5% |
| FY2023 | -$164.2M | -25.7% |
| FY2022 | -$130.7M | -194.4% |
| FY2021 | $138.4M | +1354.6% |
| FY2020 | -$11.0M | +24.5% |
| FY2019 | -$14.6M | -54.1% |
| FY2018 | -$9.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice